Lars Engelholm awarded prestigious grant to advance innovative pan-cancer therapy Patients suffering from pancreatic cancer, as well as other cancer types, may face better treatment in the future. Researchers from BRIC and Rigshospitalet are awarded a 5 million DKK Frontier Grant by LF.
Now we know why successful treatment does not affect specific cancer cells BRIC researchers reveal how glioblastoma cancer cells change appearance to avoid immunotherapy
New BRIC group leader seeks a multi-expertise approach in research Associate professor Julien Duxin is new group leader at BRIC. On June 10, 2024, Duxin-group from Center for Protein is moving to BRIC.
20 Sept. 2024, 15:00-18:00 PhD defence by Camilla Vittori Title: Pre-clinical investigation of the DNA Damage Response pathway: Synergistic effects of DNA-PK and PI3K inhibitors combined with chemotherapy to overcome resistance in acute myeloid leukaemia
10 Oct. 2024, 12:00-13:00 Bric Seminar by Justin Lathia Title: "Advanced cancer contain sex differences that impact their trajectories"